GGrantIndex
Sort

10,766 grants matching checkpoint inhibitor

Molecular Targeting of the Survivin Pathway in Cancer

$296,933
Univ Of Massachusetts Med Sch Worcester · R01 · FY2003 · CA

The Werner syndrome protein in CPT-induced DNA damage

$296,867
Lucio Comai · University Of Southern California · R01 · FY2008 · AG

Project 3: Mechanisms of immunotherapy action

$296,769
Marcia Haigis · Harvard Medical School · U54 · FY2021 · CA

Molecular Pathways in T Cell Development and Thymic Lymphoma

$296,708
Harald Von Boehmer · Dana-Farber Cancer Inst · P01 · FY2007 · CA

CONTROL OF INITIATION OF DNA REPLICATION IN LUNG CANCER

$296,625
Mount Sinai School Of Medicine Of Nyu · R01 · FY2003 · CA

CONTROL OF INITIATION OF DNA REPLICATION IN LUNG CANCER

$296,625
Mount Sinai School Of Medicine Of Nyu · R01 · FY2002 · CA

Project 1 - Integrating targeted and immune therapies for BRAF mutant colorectal cancer

$296,625
Ryan Bruce Corcoran · Dana-Farber Cancer Inst · P50 · FY2021 · CA

CONTROL OF INITIATION OF DNA REPLICATION IN LUNG CANCER

$296,625
Mount Sinai School Of Medicine Of Nyu · R01 · FY2004 · CA

Islet Growth Factors Transgenic and Viral Modeling

$296,497
Andrew F. Stewart · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · DK

DELIVERY OF SELF-REPLICATING HIV VACCINES USING IN VITRO RECONSTITUTED VIRUS-LIKE PARTICLES

$296,286
Gary Fujii · Molecular Express, Inc. · N01 · FY2017 · AI

A novel immuno-oncolytic viral therapy for the treatment of non-small cell lung carcinoma

$296,257
Stephen H Thorne · Western Oncolytics, Ltd · R44 · FY2019 · CA

Combining targeted radionuclide therapy with a localized in situ vaccine to overcome immune suppression in the tumor microenvironment and augment T cell responses

$296,214
Paul M Sondel · University Of Wisconsin-Madison · P01 · FY2024 · CA

Project 3- Integrated Stress and Interferon Responses

$296,020
Serge Y Fuchs · University Of Pennsylvania · P01 · FY2021 · CA

GENES THAT CONTROL CELL NUMBER--GI/S CHECKPOINT

$296,000
Baylor College Of Medicine · R01 · FY2000 · HL

GENES THAT CONTROL CELL NUMBER--GI/S CHECKPOINT

$296,000
Baylor College Of Medicine · R01 · FY2002 · HL

GENES THAT CONTROL CELL NUMBER--GI/S CHECKPOINT

$296,000
Baylor College Of Medicine · R01 · FY2001 · HL

Clinical specimen tumor-TME acquired resistance

$295,923
Trever G Bivona · University Of California, San Francisco · U54 · FY2024 · CA

Mitosis, Aneuploidy and Cancer

$295,769
Beth A Weaver · University Of Wisconsin-Madison · R01 · FY2014 · CA

A novel strategy to overcome drug resistance in cancer

$295,488
Aimee L Edinger · University Of California-Irvine · R01 · FY2025 · CA

Project 1

$295,336
Kunle O Odunsi · Roswell Park Cancer Institute Corp · P50 · FY2021 · CA

Project 3- Integrated Stress and Interferon Responses

$295,261
Serge Y Fuchs · University Of Pennsylvania · P01 · FY2020 · CA

Role of PI3Kinase in Tumor Progression and Metastasis

$295,139
Judith A. Varner · University Of California, San Diego · R01 · FY2021 · CA

Project 3: Improving therapeutic approaches for breast cancer brain metastases

$295,119
Jean Zhao · Dana-Farber Cancer Inst · P50 · FY2020 · CA

Project 3- Integrated Stress and Interferon Responses

$295,109
Serge Y Fuchs · University Of Pennsylvania · P01 · FY2019 · CA

Prostate cancer chemoprevention by penta-galloyl-glucose

$294,807
Junxuan Lu · Texas Tech University Health Scis Center · R01 · FY2014 · CA